Bone Matrix Graft Products Linked to Tuberculosis Risks, FDA Warns
The FDA warns that bone matrix graft products appear to be prone to tuberculosis outbreaks, and calls for more stringent screening of donors.
The FDA warns that bone matrix graft products appear to be prone to tuberculosis outbreaks, and calls for more stringent screening of donors.
A Fibercel tuberculosis lawsuit claims a man was infected with the disease through contaminated bone graft products.
An investigation into a tuberculosis outbreak linked to FiberCel bone matrix products has resulted in the CDC recommending any patients who received the bone product undergo full tuberculosis treatment.
The CDC is investigating an outbreak of tuberculosis linked to recalled FiberCel bone products.